OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragalus Mongholicus: A review of its anti-fibrosis properties
Fengying Gong, Rongmei Qu, Yongchun Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Structural elucidation and immunomodulatory activities in vitro of type I and II arabinogalactans from different origins of Astragalus membranaceus
Kaiping Wang, Yinxing Zhou, Mengqing Li, et al.
Carbohydrate Polymers (2024) Vol. 333, pp. 121974-121974
Closed Access | Times Cited: 16

Pharmacological potential of Astragali Radix for the treatment of kidney diseases
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Phytomedicine (2023) Vol. 123, pp. 155196-155196
Closed Access | Times Cited: 27

Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems
Li Song, Wei Zhang, Shiyun Tang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116039-116039
Open Access | Times Cited: 19

Astragaloside IV inhibits idiopathic pulmonary fibrosis through activation of autophagy by miR-21-mediated PTEN/PI3K/AKT/mTOR pathway
Tiaohao Li, Xiaojuan Gao, Rui Jia, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 2, pp. 128-136
Open Access | Times Cited: 5

Huajuxiaoji Formula Alleviates Phenyl Sulfate‐Induced Diabetic Kidney Disease by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis
Zeng Zhang, Yueping Bi, Fengzhu Zhou, et al.
Journal of Diabetes Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5

Nutritional, Chemical, Antioxidant and Antibacterial Screening of Astragalus cicer L. and Astragalus glycyphyllos L. Different Morphological Parts
Saba Shahrivari-Baviloliaei, Agnieszka Konopacka, Liege Aguiar Pascoalino, et al.
Foods (2025) Vol. 14, Iss. 2, pp. 250-250
Open Access

Chinese and western medicine treatment of myocardial fibrosis drugs
Yuxi Zhu, Fangmei Zhang, Zhongcheng Li, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access

Astragaloside IV inhibits nasopharyngeal carcinoma progression by suppressing the SATB2/Wnt signaling axis
Yinping Zeng, Tingting Duan, Jiajun Huang, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Open Access

The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
Tang Ziyang, Hu Xirong, An Chongming, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115625-115625
Open Access | Times Cited: 9

Efficacy and potential mechanisms of the main active ingredients of astragalus mongholicus in animal models of liver fibrosis: A systematic review and meta-analysis
Lijuan Dan, Yanwei Hao, Hongfei Song, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117198-117198
Closed Access | Times Cited: 7

Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 polarization
Yanfeng Zheng, Shaoxiu Ji, Xia Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115794-115794
Open Access | Times Cited: 7

Treatment of peritoneal fibrosis: Therapeutic prospects of bioactive Agents from Astragalus membranaceus
Ying Huang, Chenling Chu, Yuanyuan Mai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathway
Li Sheng, Jinyi Sun, Liyan Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Pharmacological potential of natural medicine Astragali Radix in treating intestinal diseases
Xiunan Wei, Xiaohui Leng, Junwei Liang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117580-117580
Open Access | Times Cited: 1

<i>Astragalus</i> (<i>Astragalus mongholicus</i>) Improves Ventricular Remodeling via ESR1 Downregulation RhoA/ROCK Pathway
Hualei Dai, Siming Tao, Yingxia Guan, et al.
International Heart Journal (2023) Vol. 64, Iss. 6, pp. 1148-1156
Open Access | Times Cited: 4

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
Junlan Tan, Jian Yi, Xianya Cao, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1963-1978
Open Access | Times Cited: 3

Research Progress on the Regulatory Mechanisms and Carriers of Astragaloside on Wound Healing Cascade Related Factors
善钊 刘
Traditional Chinese Medicine (2024) Vol. 13, Iss. 04, pp. 839-851
Closed Access

Page 1 - Next Page

Scroll to top